Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 11, 1998

View Archived Issues

Genzyme Tissue Repair: Q3 1998 highlights

Gliatech: Q3 1998 highlights

NeoRx announces license agreement with Angiotech

AltaRex seeks permission to study immunological activity of OvaRex in phase II trial

Nonpeptide CRF1 antagonist developed at Parke-Davis modulates brain NE levels

ATTRACT study establishes efficacy, safety of infliximab in RA patients

European phase III trial of Macritonin produces positive analysis of one-year BMD data

LY-300164 protects against kainate-induced neurotoxicity in vitro in a stereoselective manner

Chiron initiates phase II testing of rFGF-2

Positive phase II results reported for potential asthma treatment

Synthelabo presents in vitro, ex vivo and in vivo data on new MAO-B inhibitor

Unexpected adverse events encountered with bosentan in REACH-1 trial

Chugai describes inhibitors of iNOS, nNOS

Selective inhibitors of vascular wall, microsomal ACAT developed at Kowa

Nicotinic acetylcholine receptor ligands for nicotine addiction and CNS disorders

Pyridyl compounds claimed by Astra for the Rx of asthma and rhinitis

Proton pump inhibitors in the pipeline at Yuhan

PD-161989: novel AMPA/GLYN receptor antagonist related to PNQX

RenaGel available this month in the U.S.

Synthelabo presents new 5-HT1A inverse agonist with antagonist and anxiolytic-like activity in vivo

New anticancer drug candidate revealed by Sugen; product enters phase I testing in U.K.

Neuroprotective effects of NCC-161, a new neuronal calcium antagonist

European filing announced for Enbrel

Photoangioplasty with Antrin reduces atherosclerotic plaque in rabbit models

Inhibition of cytokine production contributes to the antiinflammatory activity of orazipone

Cytel's VLA4 antagonist shows potential for treating allergic lung inflammation

First clinical trial of oral neurophilin compound in patients with diabetic neuropathy

Improved dosage form of selegiline now on the U.K. market

Radiopharmaceutical for chronic knee synovitis in development at British university

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...